Results 201 to 210 of about 203,682 (360)
Summary Introduction Postoperative delirium is a common complication following cardiac surgery. Despite its known impact on patient outcomes, effective preventative strategies remain elusive. We aimed to perform a comprehensive Bayesian network meta‐analysis of randomised controlled trials assessing the effect of pharmacological interventions on the ...
Ivo Queiroz +16 more
wiley +1 more source
Enhancement of hippocampal interneuron excitability by NMDA receptor positive allosteric modulation. [PDF]
Xing H +14 more
europepmc +1 more source
NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation
Angela Brennan +8 more
openalex +1 more source
Reflections on Consciousness in Intensive Care
ABSTRACT Evaluating consciousness in intensive care is pivotal to relieving suffering with analgesic or sedative drugs and in prognosis and diagnoses. The usual clinical perspective is to equate consciousness with responsiveness, assuming functional motor responses and sympathetic activity of the patient. Clinical diagnoses of coma may be wrong in more
Michael Broomé, Tiit Mathiesen
wiley +1 more source
Cryo-EM snapshots of NMDA receptor activation illuminate sequential rearrangements. [PDF]
Abbott JA +5 more
europepmc +1 more source
GluN2D Subunit-Containing NMDA Receptors Control Tissue Plasminogen Activator-Mediated Spatial Memory [PDF]
Pauline Obiang +8 more
openalex +1 more source
Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander +5 more
wiley +1 more source
Psychedelics, entactogens and psychoplastogens for depression and related disorders
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley +1 more source
Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction. [PDF]
Oosterlaken M +23 more
europepmc +1 more source

